Walleye Capital’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$103K Sell
5,600
-3,600
-39% -$68.4K ﹤0.01% 3662
2025
Q4
$145K Sell
9,200
-39,200
-81% -$700K ﹤0.01% 3704
2025
Q3
$937K Buy
48,400
+26,200
+118% +$512K ﹤0.01% 2140
2025
Q2
$459K Buy
22,200
+5,200
+31% +$108K ﹤0.01% 2712
2025
Q1
$416K Buy
17,000
+12,500
+278% +$321K ﹤0.01% 2704
2024
Q4
$108K Sell
4,500
-23,500
-84% -$747K ﹤0.01% 4105
2024
Q3
$1.19M Buy
28,000
+3,900
+16% +$205K ﹤0.01% 2471
2024
Q2
$1.23M Buy
24,100
+20,600
+589% +$1.17M ﹤0.01% 2614
2024
Q1
$219K Sell
3,500
-3,200
-48% -$218K ﹤0.01% 3919
2023
Q4
$502K Sell
6,700
-6,100
-48% -$436K ﹤0.01% 2946
2023
Q3
$1.09M Buy
12,800
+5,700
+80% +$541K ﹤0.01% 2181
2023
Q2
$775K Buy
7,100
+5,100
+255% +$483K ﹤0.01% 2064
2023
Q1
$166K Buy
2,000
+1,800
+900% +$169K ﹤0.01% 2605
2022
Q4
$20.6K Sell
200
-2,400
-92% -$276K ﹤0.01% 2659
2022
Q3
$275K Buy
+2,600
New +$285K 0.01% 1894
2019
Q2
Sell
-4,400
Closed -$207K 1702
2019
Q1
$207K Buy
+4,400
New +$244K 0.03% 765

Other funds holding AMN

Walleye Capital's AMN Position: Q1 2026 in Review

Walleye Capital increased its AMN Healthcare (AMN) stake by 3,885% in Q1 2026, buying an estimated $5.18M and bringing the position to 279,702 shares worth $5.13M. The position accounts for 0.02% of the portfolio, ranked #789.

Walleye Capital first reported a position in AMN in Q3 2021 and has held it in 14 quarters since. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

  • Walleye Capital held 279,702 shares of AMN Healthcare worth $5.13M as of Q1 2026.
  • Walleye Capital bought 272,683 AMN Healthcare shares in Q1 2026, an estimated $5.18M.
  • AMN Healthcare made up 0.02% of Walleye Capital's portfolio in Q1 2026, its #789 holding.
  • Walleye Capital first reported a position in AMN Healthcare in Q3 2021 and has held it in 14 quarters since.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.